DP3 Type 1 Diabetes Targeted Research Award
Diabetes Impact Award-Closed Loop Technologies: Clinical, Physiological and Behavioral Approaches to Improve Type 1 Diabetes Outcomes (DP3)
This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing human studies to develop and/or test a highly reliable, wearable, portable, easy to operate system linking continuous glucose monitoring and pancreatic hormone delivery in a closed loop system. This research is intended to improve glucose control and quality of life of patients with type 1 diabetes. Only human studies will be considered responsive to this FOA.
|Letter of Intent Due Date|
|Application Due Date|
November 24, 2014 by 5:00 PM local time of applicant organization.